135 related articles for article (PubMed ID: 21498928)
1. Age, initial dose and dose increase are independent risk factors for symptomatic vertebral fractures in glucocorticoid-treated male patients.
Sugiyama T; Suzuki S; Yoshida T; Mayama T; Hashimoto N; Suyama K; Tanaka T; Sueishi M; Tatsuno I
Intern Med; 2011; 50(8):817-24. PubMed ID: 21498928
[TBL] [Abstract][Full Text] [Related]
2. Incidence of symptomatic vertebral fractures in women of childbearing age newly treated with high-dose glucocorticoid.
Sugiyama T; Suzuki S; Yoshida T; Suyama K; Tanaka T; Sueishi M; Tatsuno I
Gend Med; 2010 Jun; 7(3):218-29. PubMed ID: 20638627
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Symptomatic Vertebral Fractures Among Newly Diagnosed Autoimmune Diseases Initiating Glucocorticoid Therapy.
Migita K; Iwanaga N; Imadachi S; Jiuchi Y; Izumi Y; Tsuji Y; Kawahara C; Kawakami A; Furukawa H; Tohma S
Medicine (Baltimore); 2015 Jul; 94(27):e875. PubMed ID: 26166127
[TBL] [Abstract][Full Text] [Related]
4. Incidence of symptomatic vertebral fracture with high-dose glucocorticoid treatment in the Chiba-Shimoshizu Rheumatic Cohort between 1986 and 2006.
Sugiyama T; Tatsuno I; Suzuki S; Yoshida T; Tanaka T; Sueishi M; Saito Y
Endocr J; 2009; 56(4):591-9. PubMed ID: 19352047
[TBL] [Abstract][Full Text] [Related]
5. Age dependence of early symptomatic vertebral fracture with high-dose glucocorticoid treatment for collagen vascular diseases.
Tatsuno I; Sugiyama T; Suzuki S; Yoshida T; Tanaka T; Sueishi M; Saito Y
J Clin Endocrinol Metab; 2009 May; 94(5):1671-7. PubMed ID: 19258412
[TBL] [Abstract][Full Text] [Related]
6. Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic Disorders.
LeBlanc CM; Ma J; Taljaard M; Roth J; Scuccimarri R; Miettunen P; Lang B; Huber AM; Houghton K; Jaremko JL; Ho J; Shenouda N; Matzinger MA; Lentle B; Stein R; Sbrocchi AM; Oen K; Rodd C; Jurencak R; Cummings EA; Couch R; Cabral DA; Atkinson S; Alos N; Rauch F; Siminoski K; Ward LM;
J Bone Miner Res; 2015 Sep; 30(9):1667-75. PubMed ID: 25801315
[TBL] [Abstract][Full Text] [Related]
7. Current smoking is an independent risk factor for new-onset diabetes mellitus during highdose glucocorticoid treatment.
Sugiyama T; Sugimoto T; Suzuki S; Sato Y; Tanaka T; Tatsuno I
Int J Clin Pharmacol Ther; 2015 Aug; 53(8):616-20. PubMed ID: 25997545
[TBL] [Abstract][Full Text] [Related]
8. High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the alendronate or alfacalcidol in glucocorticoid-induced osteoporosis-trial.
Hoes JN; Jacobs JW; Hulsmans HM; De Nijs RN; Lems WF; Bruyn GA; Geusens PP; Bijlsma JW
Clin Exp Rheumatol; 2010; 28(3):354-9. PubMed ID: 20406615
[TBL] [Abstract][Full Text] [Related]
9. Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in Japan.
Iki M; Fujimori K; Nakatoh S; Tamaki J; Ishii S; Okimoto N; Imano H; Ogawa S
Osteoporos Int; 2024 May; 35(5):805-818. PubMed ID: 38267664
[TBL] [Abstract][Full Text] [Related]
10. Effects of Systemic Glucocorticoid Use on Fracture Risk: A Population-Based Study.
Koh JW; Kim J; Cho H; Ha YC; Kim TY; Lee YK; Kim HY; Jang S
Endocrinol Metab (Seoul); 2020 Sep; 35(3):562-570. PubMed ID: 32981298
[TBL] [Abstract][Full Text] [Related]
11. Notable difference between the development of vertebral fracture and osteonecrosis of the femoral head in patients treated with high-dose glucocorticoids for systemic rheumatic diseases.
Kameda H; Amano K; Nagasawa H; Ogawa H; Sekiguchi N; Takei H; Suzuki K; Takeuchi T
Intern Med; 2009; 48(22):1931-8. PubMed ID: 19915292
[TBL] [Abstract][Full Text] [Related]
12. Vertebral fracture and bone mineral density in women receiving high dose glucocorticoids for treatment of autoimmune diseases.
Kumagai S; Kawano S; Atsumi T; Inokuma S; Okada Y; Kanai Y; Kaburaki J; Kameda H; Suwa A; Hagiyama H; Hirohata S; Makino H; Hashimoto H
J Rheumatol; 2005 May; 32(5):863-9. PubMed ID: 15868623
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis.
de Nijs RN; Jacobs JW; Bijlsma JW; Lems WF; Laan RF; Houben HH; ter Borg EJ; Huisman AM; Bruyn GA; van Oijen PL; Westgeest AA; Algra A; Hofman DM;
Rheumatology (Oxford); 2001 Dec; 40(12):1375-83. PubMed ID: 11752508
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for established vertebral fractures in Japanese patients with rheumatoid arthritis: Results from a large prospective observational cohort study.
Ishida O; Furuya T; Inoue E; Ochi K; Ikari K; Taniguchi A; Yamanaka H; Momohara S
Mod Rheumatol; 2015 May; 25(3):373-8. PubMed ID: 25797805
[TBL] [Abstract][Full Text] [Related]
15. Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study.
Rodd C; Lang B; Ramsay T; Alos N; Huber AM; Cabral DA; Scuccimarri R; Miettunen PM; Roth J; Atkinson SA; Couch R; Cummings EA; Dent PB; Ellsworth J; Hay J; Houghton K; Jurencak R; Larché M; LeBlanc C; Oen K; Saint-Cyr C; Stein R; Stephure D; Taback S; Lentle B; Matzinger M; Shenouda N; Moher D; Rauch F; Siminoski K; Ward LM;
Arthritis Care Res (Hoboken); 2012 Jan; 64(1):122-31. PubMed ID: 22213727
[TBL] [Abstract][Full Text] [Related]
16. Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink.
Abtahi S; Driessen JHM; Burden AM; Souverein PC; van den Bergh JP; van Staa TP; Boonen A; de Vries F
Rheumatology (Oxford); 2022 Apr; 61(4):1448-1458. PubMed ID: 34255815
[TBL] [Abstract][Full Text] [Related]
17. Risk factors associated with the occurrence of proximal humerus fractures in patients with rheumatoid arthritis: a custom strategy for preventing proximal humerus fractures.
Ochi K; Furuya T; Ishibashi M; Watanabe M; Ikari K; Taniguchi A; Yamanaka H; Momohara S
Rheumatol Int; 2016 Feb; 36(2):213-9. PubMed ID: 26420406
[TBL] [Abstract][Full Text] [Related]
18. A case of multiple vertebral compression fractures due to glucocorticoid-induced osteoporosis in a pediatric patient with nephrotic syndrome
.
Ashida A; Fujii Y; Matsumura H; Tamai H
Int J Clin Pharmacol Ther; 2017 Mar; 55(3):264-269. PubMed ID: 27936525
[TBL] [Abstract][Full Text] [Related]
19. Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort.
Bours S; de Vries F; van den Bergh JPW; Lalmohamed A; van Staa TP; Leufkens HGM; Geusens PPP; Drent M; Harvey NC
Osteoporos Int; 2016 Apr; 27(4):1603-1610. PubMed ID: 26630976
[TBL] [Abstract][Full Text] [Related]
20. Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case-control study.
Amiche MA; Abtahi S; Driessen JHM; Vestergaard P; de Vries F; Cadarette SM; Burden AM
Arch Osteoporos; 2018 Mar; 13(1):30. PubMed ID: 29552730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
